Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-05-23 @ 11:53 PM
Study NCT ID:
NCT05708534
Status:
RECRUITING
Last Update Posted:
2025-06-26
First Post:
2023-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Sponsor:
University Hospital, Rouen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020/0432/OB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None